Correction: Fibroblast growth factor receptor 4 induced resistance to radiation therapy in colorectal cancer

Affiliations

¹ Institute of Cancer Research, Department of Medicine I, Medical University of Vienna, Austria.
² Radiation Biology Department, National Center for Radiation Research and Technology, Egyptian Atomic Energy Authority, Egypt.
³ Department of Radiotherapy and Radiobiology, Medical University of Vienna, Austria.
⁴ Christian Doppler Laboratory for Medical Radiation Research for Radiation Oncology, Medical University of Vienna, Austria.
⁵ Department of Surgery, Medical University Vienna, Austria.
⁶ Clinical Institute of Pathology, Medical University Vienna, Austria.

Published Erratum

Mohamed A Ahmed et al. Oncotarget. 2019.

. 2019 Sep 3;10(51):5385-5386.

doi: 10.18632/oncotarget.27186.

¹ Institute of Cancer Research, Department of Medicine I, Medical University of Vienna, Austria.
² Radiation Biology Department, National Center for Radiation Research and Technology, Egyptian Atomic Energy Authority, Egypt.
³ Department of Radiotherapy and Radiobiology, Medical University of Vienna, Austria.
⁴ Christian Doppler Laboratory for Medical Radiation Research for Radiation Oncology, Medical University of Vienna, Austria.
⁵ Department of Surgery, Medical University Vienna, Austria.
⁶ Clinical Institute of Pathology, Medical University Vienna, Austria.

Abstract

[This corrects the article DOI: 10.18632/oncotarget.12099.].

Fibroblast growth factor receptor 4 induced resistance to radiation therapy in colorectal cancer.
Ahmed MA, Selzer E, Dörr W, Jomrich G, Harpain F, Silberhumer GR, Müllauer L, Holzmann K, Grasl-Kraupp B, Grusch M, Berger W, Marian B. Ahmed MA, et al. Oncotarget. 2016 Oct 25;7(43):69976-69990. doi: 10.18632/oncotarget.12099. Oncotarget. 2016. PMID: 27650548 Free PMC article.